Drawing investor attention can pose a challenge, even for companies with groundbreaking, new science. In a space teeming with competition, it’s vital that emerging biophama companies developing innovative therapies also establish strong messaging to reach and intrigue potential investors.
Posts by Stephanie Carrington
Stephanie Carrington is a Managing Director on Westwicke's life sciences team. She has extensive experience in healthcare investor relations and strategic communications. She has a BA in economics and international relations from Smith College and an MBA in finance and international business from New York University’s Stern School of Business.
A crisis can break in an instant. Are you prepared?
Use our eBook to develop a plan for the year ahead. Download Now.